GenMark Diagnostics, Inc. (Nasdaq: GNMK) announced today that its initial public offering of 4,600,000 shares of its common stock has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE